| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal oestrogen receptor in clinical breast cancer
|
McGuire, William L.
|
|
1992
|
28 |
2-3 |
p. 309-310
2 p.
|
artikel
|
| 2 |
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients
|
Dowsett, M.
|
|
1992
|
28 |
2-3 |
p. 415-420
6 p.
|
artikel
|
| 3 |
Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients
|
Campbell, A.M.
|
|
1992
|
28 |
2-3 |
p. 357-362
6 p.
|
artikel
|
| 4 |
Annual meeting of the AACR
|
|
|
1992
|
28 |
2-3 |
p. 604-
1 p.
|
artikel
|
| 5 |
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer
|
Willemse, P.H.B.
|
|
1992
|
28 |
2-3 |
p. 479-481
3 p.
|
artikel
|
| 6 |
A phase II study of metastatic melanoma treated with a combination of interferon Alfa2b, dacarbazine and nimustine
|
Gröhn, P.
|
|
1992
|
28 |
2-3 |
p. 441-443
3 p.
|
artikel
|
| 7 |
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma
|
Fiedler, W.
|
|
1992
|
28 |
2-3 |
p. 443-446
4 p.
|
artikel
|
| 8 |
A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma
|
Given, H.F.
|
|
1992
|
28 |
2-3 |
p. 658-660
3 p.
|
artikel
|
| 9 |
BACR/ACP joint annual meetings
|
|
|
1992
|
28 |
2-3 |
p. 604-
1 p.
|
artikel
|
| 10 |
Breast cancer: Adjuvant treatment
|
Rubens, R.D.
|
|
1992
|
28 |
2-3 |
p. 620-622
3 p.
|
artikel
|
| 11 |
Breast cancer, blindness and melatonin
|
Coleman, M.P.
|
|
1992
|
28 |
2-3 |
p. 501-503
3 p.
|
artikel
|
| 12 |
Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses
|
Silverstein, Melvin J.
|
|
1992
|
28 |
2-3 |
p. 635-640
6 p.
|
artikel
|
| 13 |
Breast cancer: Lots of data, steady but slow clinical progress
|
van der Schueren, E.
|
|
1992
|
28 |
2-3 |
p. 317-
1 p.
|
artikel
|
| 14 |
Breast conserving therapy: Workshop report
|
Fentiman, Ian S.
|
|
1992
|
28 |
2-3 |
p. 619-620
2 p.
|
artikel
|
| 15 |
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma
|
Schifter, Søren
|
|
1992
|
28 |
2-3 |
p. 341-345
5 p.
|
artikel
|
| 16 |
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial
|
Boccardo, F.
|
|
1992
|
28 |
2-3 |
p. 673-680
8 p.
|
artikel
|
| 17 |
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer
|
Gundersen, S.
|
|
1992
|
28 |
2-3 |
p. 390-394
5 p.
|
artikel
|
| 18 |
Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma
|
Jassem, J.
|
|
1992
|
28 |
2-3 |
p. 473-476
4 p.
|
artikel
|
| 19 |
Consensus on the management of melanoma of the skin in The Netherlands
|
Rümke, Ph.
|
|
1992
|
28 |
2-3 |
p. 600-604
5 p.
|
artikel
|
| 20 |
Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil
|
Casinu, Stefano
|
|
1992
|
28 |
2-3 |
p. 482-483
2 p.
|
artikel
|
| 21 |
Correction
|
|
|
1992
|
28 |
2-3 |
p. 616-
1 p.
|
artikel
|
| 22 |
Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron
|
du Bois, A.
|
|
1992
|
28 |
2-3 |
p. 450-457
8 p.
|
artikel
|
| 23 |
Cytotoxicity of 5-Aza-2′-deoxycytidine in a mammalian cell system
|
Davidson, Sean
|
|
1992
|
28 |
2-3 |
p. 362-368
7 p.
|
artikel
|
| 24 |
Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7
|
Altmann, A.
|
|
1992
|
28 |
2-3 |
p. 326-333
8 p.
|
artikel
|
| 25 |
Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays
|
Beckmann, M.W.
|
|
1992
|
28 |
2-3 |
p. 322-326
5 p.
|
artikel
|
| 26 |
Dietary factors in lung cancer prognosis
|
Goodman, Marc T.
|
|
1992
|
28 |
2-3 |
p. 495-501
7 p.
|
artikel
|
| 27 |
DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer
|
O'Reilly, S.M.
|
|
1992
|
28 |
2-3 |
p. 681-683
3 p.
|
artikel
|
| 28 |
DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study
|
Jakesz, R.
|
|
1992
|
28 |
2-3 |
p. 711-716
6 p.
|
artikel
|
| 29 |
Does the breast cancer dollar make sense?
|
Epstein, Richard J.
|
|
1992
|
28 |
2-3 |
p. 486-491
6 p.
|
artikel
|
| 30 |
Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer
|
Beex, L.V.A.M.
|
|
1992
|
28 |
2-3 |
p. 686-690
5 p.
|
artikel
|
| 31 |
Ductal carcinoma in situ of the breast: Do we still need trials?
|
Fentiman, I.S.
|
|
1992
|
28 |
2-3 |
p. 317-318
2 p.
|
artikel
|
| 32 |
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting
|
van Dongen, J.A.
|
|
1992
|
28 |
2-3 |
p. 626-629
4 p.
|
artikel
|
| 33 |
Duct carcinoma in situ: 227 cases without microinvasion
|
Silverstein, Melvin J.
|
|
1992
|
28 |
2-3 |
p. 630-634
5 p.
|
artikel
|
| 34 |
Effect of interleukin-3 and granulocyte-macrophage colony-stimulating factor on growth of xenotransplanted human tumour cell lines in nude mice
|
Berdel, W.E.
|
|
1992
|
28 |
2-3 |
p. 377-380
4 p.
|
artikel
|
| 35 |
Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology
|
Koenders, P.G.
|
|
1992
|
28 |
2-3 |
p. 693-697
5 p.
|
artikel
|
| 36 |
Expression of c-erbB2, TGF-β1 and pS2 genes in primary human breast cancers
|
Winkler-Gol, R.A.
|
|
1992
|
28 |
2-3 |
p. 700-705
6 p.
|
artikel
|
| 37 |
Expression of pp60c-src in human small cell and non-small cell lung carcinomas
|
Mazurenko, N.N.
|
|
1992
|
28 |
2-3 |
p. 372-377
6 p.
|
artikel
|
| 38 |
Factors influencing the risk of local recurrence in the breast
|
Kurtz, John M.
|
|
1992
|
28 |
2-3 |
p. 660-666
7 p.
|
artikel
|
| 39 |
Flow cytometric analysis of tumour-draining lymph nodes in breast cancer patients
|
Campbell, A.M.
|
|
1992
|
28 |
2-3 |
p. 350-356
7 p.
|
artikel
|
| 40 |
Follow-up in patients treated for head and neck cancer: How frequent, how thorough and for how long?
|
Snow, Gordon B.
|
|
1992
|
28 |
2-3 |
p. 315-316
2 p.
|
artikel
|
| 41 |
1992 Forthcoming educational events
|
|
|
1992
|
28 |
2-3 |
p. 605-
1 p.
|
artikel
|
| 42 |
Head activator as a potential serum marker for brain tumour analysis
|
Schaller, H.C.
|
|
1992
|
28 |
2-3 |
p. 421-424
4 p.
|
artikel
|
| 43 |
High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in metastatic colorectal cancer: a 3-day/3-week schedule
|
Louvet, Christophe
|
|
1992
|
28 |
2-3 |
p. 611-612
2 p.
|
artikel
|
| 44 |
Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitro
|
Tevaearai, H.T.
|
|
1992
|
28 |
2-3 |
p. 368-372
5 p.
|
artikel
|
| 45 |
Interferon alpha2a and vindesine in the treatment of advanced malignant melanoma
|
Green, J.A.
|
|
1992
|
28 |
2-3 |
p. 438-441
4 p.
|
artikel
|
| 46 |
Intra-arterial cisplatin in advanced squamous cell carcinoma of the bladder
|
Wishahi, M.
|
|
1992
|
28 |
2-3 |
p. 612-613
2 p.
|
artikel
|
| 47 |
Is DNA flow cytometry a useful investigation in breast cancer?
|
O'Reilly, S.M.
|
|
1992
|
28 |
2-3 |
p. 504-507
4 p.
|
artikel
|
| 48 |
Lack of effect of tumour infiltrating lymphocytes in patients with metastatic melanoma who failed to respond to interleukin 2
|
Dorval, T.
|
|
1992
|
28 |
2-3 |
p. 615-616
2 p.
|
artikel
|
| 49 |
Long-term prognostic significance of thymidine labelling index in primary breast cancer
|
Cooke, T.G.
|
|
1992
|
28 |
2-3 |
p. 424-426
3 p.
|
artikel
|
| 50 |
Meningeal carcinomatosis in urothelial cancer
|
Mack, D.
|
|
1992
|
28 |
2-3 |
p. 614-
1 p.
|
artikel
|
| 51 |
Metastasis research society
|
|
|
1992
|
28 |
2-3 |
p. 604-
1 p.
|
artikel
|
| 52 |
Metastatic ovarian or colonic cancer: A clinical challenge
|
Taal, B.G.
|
|
1992
|
28 |
2-3 |
p. 394-399
6 p.
|
artikel
|
| 53 |
Mitogenic effects of epidermal growth factor and transforming growth factor-α on EGF-receptor positive human ovarian carcinoma cell lines
|
Crew, A. Jayne
|
|
1992
|
28 |
2-3 |
p. 337-341
5 p.
|
artikel
|
| 54 |
Monoclonal antibodies in the treatment of central nervous system malignancies
|
Kemshead, John T.
|
|
1992
|
28 |
2-3 |
p. 511-513
3 p.
|
artikel
|
| 55 |
Mutations in the ras protooncogenes are rare events in renal cell cancer
|
Rochlitz, C.F.
|
|
1992
|
28 |
2-3 |
p. 333-336
4 p.
|
artikel
|
| 56 |
[No title]
|
Begg, A.
|
|
1992
|
28 |
2-3 |
p. 608-
1 p.
|
artikel
|
| 57 |
[No title]
|
Oliver, R.T.D.
|
|
1992
|
28 |
2-3 |
p. 609-
1 p.
|
artikel
|
| 58 |
[No title]
|
Fentiman, Ian
|
|
1992
|
28 |
2-3 |
p. 609-
1 p.
|
artikel
|
| 59 |
Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
|
Barnes, D.M.
|
|
1992
|
28 |
2-3 |
p. 644-648
5 p.
|
artikel
|
| 60 |
Parathyroid hormone related protein and skeletal morbidity in breast cancer
|
Bundred, N.J.
|
|
1992
|
28 |
2-3 |
p. 690-692
3 p.
|
artikel
|
| 61 |
Parotid gland function during and following radiotherapy of malignancies in the head and neck
|
Franzén, Lars
|
|
1992
|
28 |
2-3 |
p. 457-462
6 p.
|
artikel
|
| 62 |
PET scanning in oncology
|
Wilson, C.B.J.H.
|
|
1992
|
28 |
2-3 |
p. 508-510
3 p.
|
artikel
|
| 63 |
Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study
|
Osborne, C.K.
|
|
1992
|
28 |
2-3 |
p. 477-478
2 p.
|
artikel
|
| 64 |
Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck
|
Cappelaere, P.
|
|
1992
|
28 |
2-3 |
p. 484-485
2 p.
|
artikel
|
| 65 |
Phase I study of subcutaneously-administered bacterially-synthesised recombinant human granulocyte-macrophage colony-stimulating factor
|
Schwartz, G.K.
|
|
1992
|
28 |
2-3 |
p. 470-473
4 p.
|
artikel
|
| 66 |
Phase I trial of the anthrapyrazole CI-941: Prospective evaluation of a pharmacokinetically guided dose-escalation
|
Foster, B.J.
|
|
1992
|
28 |
2-3 |
p. 463-469
7 p.
|
artikel
|
| 67 |
Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancers
|
Mathiot, C.
|
|
1992
|
28 |
2-3 |
p. 345-350
6 p.
|
artikel
|
| 68 |
Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas
|
Phillips, Marianne B.
|
|
1992
|
28 |
2-3 |
p. 399-403
5 p.
|
artikel
|
| 69 |
Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trials
|
Auquier, A.
|
|
1992
|
28 |
2-3 |
p. 433-437
5 p.
|
artikel
|
| 70 |
Potentials of cell kinetics in the management of patients with ovarian cancers
|
Silvestrini, R.
|
|
1992
|
28 |
2-3 |
p. 386-390
5 p.
|
artikel
|
| 71 |
Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors
|
Berns, Els M.J.J.
|
|
1992
|
28 |
2-3 |
p. 697-700
4 p.
|
artikel
|
| 72 |
Progress in molecular biology of breast cancer
|
Mooi, Wolter J.
|
|
1992
|
28 |
2-3 |
p. 623-625
3 p.
|
artikel
|
| 73 |
Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy
|
Martin, Miguel
|
|
1992
|
28 |
2-3 |
p. 430-432
3 p.
|
artikel
|
| 74 |
Quality control of EORTC case report forms—Wider implications for trial management
|
Franklin, H.
|
|
1992
|
28 |
2-3 |
p. 610-611
2 p.
|
artikel
|
| 75 |
Radical surgery and conservative treatment of ductal carcinoma in situ of the breast
|
Cutuli, B.
|
|
1992
|
28 |
2-3 |
p. 649-654
6 p.
|
artikel
|
| 76 |
Screening and treatment of screen-detected cancer
|
Miller, Anthony B.
|
|
1992
|
28 |
2-3 |
p. 617-619
3 p.
|
artikel
|
| 77 |
Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway
|
Akslen, L.A.
|
|
1992
|
28 |
2-3 |
p. 491-495
5 p.
|
artikel
|
| 78 |
Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma—an effective combination with unexpected toxicity
|
Aamdal, S.
|
|
1992
|
28 |
2-3 |
p. 447-450
4 p.
|
artikel
|
| 79 |
Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours
|
von Eyben, F.E.
|
|
1992
|
28 |
2-3 |
p. 410-415
6 p.
|
artikel
|
| 80 |
Systemic treatment for locally advanced breast cancer: What we still need to learn after a decade of multimodality clinical trials
|
Piccart, M.J.
|
|
1992
|
28 |
2-3 |
p. 667-672
6 p.
|
artikel
|
| 81 |
Tamoxifen protects against steroid-induced bone loss
|
Fentiman, I.S.
|
|
1992
|
28 |
2-3 |
p. 684-685
2 p.
|
artikel
|
| 82 |
Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro
|
Antoniotti, S.
|
|
1992
|
28 |
2-3 |
p. 318-321
4 p.
|
artikel
|
| 83 |
Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol
|
Konno, T.
|
|
1992
|
28 |
2-3 |
p. 403-409
7 p.
|
artikel
|
| 84 |
The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow
|
Testa, N.G.
|
|
1992
|
28 |
2-3 |
p. 381-386
6 p.
|
artikel
|
| 85 |
The use of palliative radiotherapy in the management of breast cancer
|
Maher, E.J.
|
|
1992
|
28 |
2-3 |
p. 706-710
5 p.
|
artikel
|
| 86 |
The value of follow-up in patients treated for squamous cell carcinoma of the head and neck
|
Boysen, M.
|
|
1992
|
28 |
2-3 |
p. 426-430
5 p.
|
artikel
|
| 87 |
8th International hammersmith meeting on advances in applications of monoclonal antibodies in clinical oncology, 8–13 May 1991
|
Chester, Kerry A.
|
|
1992
|
28 |
2-3 |
p. 606-608
3 p.
|
artikel
|
| 88 |
Tobacco or health: a WHO programme
|
Chollat-Traquet, C.
|
|
1992
|
28 |
2-3 |
p. 311-315
5 p.
|
artikel
|
| 89 |
Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast
|
Walker, Rosemary A.
|
|
1992
|
28 |
2-3 |
p. 641-644
4 p.
|
artikel
|
| 90 |
Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine
|
Price, B.A.
|
|
1992
|
28 |
2-3 |
p. 615-
1 p.
|
artikel
|
| 91 |
Treatment of recurrent gynaecologic malignancies with a new camptothecin derivative
|
Mori, H.
|
|
1992
|
28 |
2-3 |
p. 613-
1 p.
|
artikel
|
| 92 |
Trends of cancer mortality in Europe, 1955–1989: II, respiratory tract, bone, connective and soft tissue sarcomas, and skin
|
La Vecchia, C.
|
|
1992
|
28 |
2-3 |
p. 514-599
86 p.
|
artikel
|
| 93 |
Which therapy for unexpected phyllode tumour of the breast?
|
Zurrida, S.
|
|
1992
|
28 |
2-3 |
p. 654-657
4 p.
|
artikel
|
Tijdschrift beschrijving